Shockwave Medical Announces CE Mark Approval Of Its Lithoplasty System For The Treatment Of Peripheral Artery Disease

Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, recently announced CE Mark regulatory approval for the company’s Lithoplasty balloon catheters for the treatment of peripheral artery disease (PAD). Lithoplasty is a novel balloon-based technology that utilizes integrated lithotripsy, a pulsatile mechanical energy commonly used to break up kidney stones, to disrupt both superficial and deep calcium and normalize vessel wall compliance prior to low-pressure balloon dilatation.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news